Analysts Set Nektar Therapeutics (NASDAQ:NKTR) PT at $1.50

Shares of Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) have earned a consensus rating of “Hold” from the five brokerages that are covering the firm, MarketBeat reports. One investment analyst … [+3321 chars]

Ads Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute
The Effects of Hemp Edibles: What Happens When You Consume Cannabinoids?
Has a UC Berkeley chemistry lab discovered the holy grail of plastic recycling?

Southern Chiefs' Organization takes government to court to have Lake Winnipeg declared a living entity
Core One Labs (OTCMKTS:CLABF) Shares Up 20%